))
Developments in Parkinson's Diagnosis: New Tests, Alpha-Synuclein, and Looking Forward (Part 2)
Manage episode 458685116 series 3632855
Contenido proporcionado por Davis Phinney Foundation. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Davis Phinney Foundation o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Click here to subscribe for our podcast and video content on YouTube.
In this episode, Dr. Arash Fazl discusses the role of the protein alpha-synuclein in Parkinson’s and how this protein is involved in new diagnostic tests for Parkinson’s. Dr. Fazl also shares how these new tests may contribute to additional exciting developments in the future.
This is part two of a two-part series about Parkinson’s diagnosis. In the first episode, Dr. Fazl describes the challenges involved in diagnosing Parkinson’s. This episode picks up in the middle of our conversation with Dr. Fazl, right where we ended the first episode.
This two-part series is sponsored by CND Life sciences, home of the Syn-One Test - the first commercially available skin-based test to help clinicians diagnose Parkinson’s disease and related disorders.
Listen to Part 1 of this podcast series here: https://youtu.be/98AUXc2pgHo
This two-part series is sponsored by CND Life sciences, home of the Syn-One Test - the first commercially available skin-based test to help clinicians diagnose Parkinson’s disease and related disorders.
For more information about the Davis Phinney Foundation visit: https://dpf.org
Season 5 episode 36
100 episodios
Compartir
